These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 17850780)
1. Measurement of serum paraoxonase-1 activity as a potential biomarker for chronic liver impairment. Camps J; Marsillach J; Joven J Clin Chim Acta; 2007; 386(1-2):114-5. PubMed ID: 17850780 [No Abstract] [Full Text] [Related]
2. Serum paraoxonase-3 concentration is associated with the severity of hepatic impairment in patients with chronic liver disease. García-Heredia A; Marsillach J; Aragonès G; Guardiola M; Rull A; Beltrán-Debón R; Folch A; Mackness B; Mackness M; Pedro-Botet J; Joven J; Camps J Clin Biochem; 2011 Nov; 44(16):1320-4. PubMed ID: 21854763 [TBL] [Abstract][Full Text] [Related]
3. Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseases. Ferré N; Marsillach J; Camps J; Mackness B; Mackness M; Riu F; Coll B; Tous M; Joven J J Hepatol; 2006 Jul; 45(1):51-9. PubMed ID: 16510204 [TBL] [Abstract][Full Text] [Related]
4. Paraoxonase activity in sera of patients with non-alcoholic fatty liver disease. Fedelesova M; Kupcova V; Luha J; Turecky L Bratisl Lek Listy; 2017; 118(12):719-720. PubMed ID: 29322801 [TBL] [Abstract][Full Text] [Related]
5. Serum paraoxonase and arylesterase activities for the evaluation of patients with chronic hepatitis. Aslan M; Horoz M; Nazligul Y; Bolukbas C; Bolukbas FF; Selek S; Aksoy N; Erel O Int J Clin Pract; 2008 Jul; 62(7):1050-5. PubMed ID: 17887991 [TBL] [Abstract][Full Text] [Related]
6. Baseline and salt-stimulated paraoxonase and arylesterase activities in patients with chronic liver disease: relation to disease severity. Keskin M; Dolar E; Dirican M; Kiyici M; Yilmaz Y; Gurel S; Nak SG; Erdinc S; Gulten M Intern Med J; 2009 Apr; 39(4):243-8. PubMed ID: 19402863 [TBL] [Abstract][Full Text] [Related]
7. Iron and chronic viral hepatitis. Bonkovsky HL; Banner BF; Rothman AL Hepatology; 1997 Mar; 25(3):759-68. PubMed ID: 9049232 [No Abstract] [Full Text] [Related]
8. [Clinical value of measuring the activity of serum cholinesterase and its isoenzyme in chronic hepatitis and liver cirrhosis]. Karlinskiĭ VM; Breĭdo EV; Falikovich MIa; Iskakov BS; Beĭsetaev OB; Baranov NP; Bekenova FK Klin Med (Mosk); 1991 Jun; 69(6):85-7. PubMed ID: 1774923 [TBL] [Abstract][Full Text] [Related]
9. [Methodolgy and interpretation in the study of the complement system in chronic hepatitis]. Moroşanu V; Papp E; Ionescu L; Niţescu S; Caraman D Rev Med Chir Soc Med Nat Iasi; 1982; 86(2):273-6. PubMed ID: 25588250 [TBL] [Abstract][Full Text] [Related]
18. Gender related differences in paraoxonase 1 response to high-fat diet-induced oxidative stress. Thomàs-Moyà E; Gómez-Pérez Y; Fiol M; Gianotti M; Lladó I; Proenza AM Obesity (Silver Spring); 2008 Oct; 16(10):2232-8. PubMed ID: 18719679 [TBL] [Abstract][Full Text] [Related]
19. [The significance of the content of connective tissue metabolites in the blood serum for the diagnosis of chronic viral hepatitis and liver cirrhosis]. Smirnov BM; Trishkova LA Lik Sprava; 1992 Jan; (1):81-4. PubMed ID: 1364619 [TBL] [Abstract][Full Text] [Related]
20. Serum ceruloplasmin in cirrhosis and chronic active hepatitis. Hasan A; Hameed F; Husain Z; Ansari MG Indian J Pathol Microbiol; 1985 Jul; 28(3):211-4. PubMed ID: 3835123 [No Abstract] [Full Text] [Related] [Next] [New Search]